PTCB Pharmacy Technician (PTCE) — All Questions

A prescriber writes an order for an oral liquid antipsychotic as "1.0 mg by mouth at bedtime." Why is this way of writing the dose considered unsafe?

• a.Doses below 10 mg must always be expressed in mcg
• b.A decimal point is never permitted in an order for a liquid medication
• c.If the decimal point is missed or lost, 1.0 mg is read as 10 mg, a ten-fold overdose✓
• d.The trailing zero shows the dose was rounded and is therefore only an estimate

A trailing zero adds no clinical information but creates real danger: if the decimal point is faint or lost in transmission, 1.0 mg is read as 10 mg. The safe convention is the opposite pair of rules: never use a trailing zero (write 1 mg), but always use a leading zero for doses under one (write 0.5 mg, not .5 mg). Small doses are not converted to mcg simply for being small, decimal points are allowed in liquid orders, and a trailing zero says nothing about rounding.

A handwritten order reads "Humulin R 8U subcutaneously before meals." Which correction should be made before the order is processed?

• a.Have "U" spelled out as "units," because U can be misread as a zero or a four✓
• b.Abbreviate "subcutaneously" to "SQ" to save more room on the label
• c.Replace "before meals" with the shorter frequency abbreviation "QD"
• d.Rewrite the dose as "8.0 units" so the decimal place is clear

The symbol U is one of the most dangerous abbreviations in practice: 8U can be read as 80 or 84, turning an 8 unit insulin dose into a potentially fatal one, so the word units must be written out in full. SQ is itself on the do-not-use list because it is misread as SL, writing 8.0 units introduces a trailing zero that is read as 80 if the decimal point is missed, and QD is on every do-not-use list because it is confused with QOD and QID.

While filling a prescription, a technician scans the barcode on the stock bottle and the dispensing system rejects the scan. What is the correct next action?

• a.Skip the scan and rely on the pharmacist to catch any problem at the final verification instead
• b.Rescan the bottle repeatedly until the system finally accepts it and lets the fill continue
• c.Type the NDC from the stock bottle in by hand and continue filling the prescription as usual
• d.Stop, set the bottle aside, and confirm that the product truly matches the prescription label before going any further✓

A rejected scan is the system telling the technician that the product in hand is not the product on the label, so the fill must stop until the discrepancy is resolved. Typing the NDC by hand, rescanning until the system gives way, and skipping the scan all defeat the purpose of barcode verification, which is an independent electronic check that does not depend on the eyes of the person filling. Relying on the pharmacist's final verification alone removes one layer of protection instead of adding one.FDA

A pediatric order is written for 15 mg/kg per dose for a child who weighs 18 kg. The label produced by the system reads "2,700 mg per dose." What should the technician conclude?

• a.The dose must be recalculated using the child's weight in pounds
• b.The label is correct but the dose should be rounded up to 2,750 mg for easier measuring
• c.The label is correct, because 18 kg multiplied by 15 mg/kg equals 2,700 mg
• d.The label shows a ten-fold overdose; the correct dose is 270 mg per dose✓

18 kg x 15 mg/kg = 270 mg per dose, so 2,700 mg is exactly ten times the intended amount and the label must be stopped and given to the pharmacist. Accepting 2,700 mg repeats the decimal error, and rounding it to 2,750 mg only makes an overdose easier to measure. Weight-based pediatric doses are calculated in kg, so converting to pounds would inflate the dose further.

Technicians are taught to read each prescription three times during the fill process. At which three points should those readings occur?

• a.When the stock bottle is taken off the shelf, when the drug is counted or measured, and when the bottle is returned to the shelf✓
• b.Three times in quick succession at the counting tray, immediately before the tablets are counted out
• c.Once by the technician at drug selection and twice by the pharmacist during the final verification
• d.At drop-off, at the cash register when payment is taken, and again at the pickup window

The three readings are spaced across the physical steps of the fill — selection, counting, and return to stock — so that a wrong-drug or wrong-strength selection is caught at a different moment each time. Three readings in quick succession at the counting tray use the same glance and the same assumption, so they catch almost nothing. Drop-off, payment, and pickup are service steps rather than fill checks, and the technique is a technician self-check that adds to the pharmacist's verification rather than replacing part of it.

Insulin, heparin, warfarin, opioids and concentrated potassium chloride are all classified as high-alert medications. What does that classification mean?

• a.Dispensing errors happen far more frequently with these drugs than with any other medications
• b.An error involving them is far more likely to cause severe or fatal harm, even though errors are not necessarily more frequent✓
• c.They may be dispensed only in unit-dose packaging prepared by the manufacturer, never repackaged
• d.They are the most expensive products the pharmacy carries and are kept locked in the pharmacy safe

High-alert status is about the consequence of an error, not its frequency: these drugs have a narrow margin between a therapeutic dose and a harmful one, so a single mistake can kill. That is why they warrant an independent double check, physical separation from look-alike stock, and standardized concentrations. High-alert drugs are dispensed in ordinary packaging every day, several of them are inexpensive generics, and error frequency is not what puts a drug on the list.

A heparin infusion is prepared by adding 25,000 units of heparin to a 250 mL bag of diluent. Which final concentration should appear on the label?

• a.25 units/mL
• b.100 units/mL✓
• c.10 units/mL
• d.1,000 units/mL

25,000 units divided by 250 mL equals 100 units/mL, and because heparin is a high-alert drug this figure should be confirmed by an independent double check before the bag is released. 10 units/mL and 25 units/mL understate the concentration, while 1,000 units/mL is a ten-fold overstatement that would lead a nurse to infuse far too little or far too much heparin for the ordered rate.

An order calls for potassium chloride 20 mEq to be added to 100 mL of diluent. The stock vial is labeled 2 mEq/mL. What volume should be withdrawn?

• a.2 mL
• b.40 mL
• c.10 mL✓
• d.20 mL

20 mEq divided by 2 mEq/mL equals 10 mL, which is then added to the 100 mL bag. Withdrawing 2 mL or 20 mL would deliver 4 mEq or 40 mEq, and 40 mL would give 80 mEq — four times the order. Concentrated potassium chloride is a high-alert product that must always be diluted before administration and never dispensed as an undiluted vial to a patient care area.

A prescription reads "insulin glargine 14 units subcutaneously at bedtime," but the label that printed reads "inject 14 mL subcutaneously at bedtime." What should the technician do?

• a.Dispense it exactly as printed, since 14 mL of U-100 insulin works out to the same dose as 14 units
• b.Dispense it with a U-100 insulin syringe so that the patient can convert the dose before injecting it
• c.Correct the label to read 14 mL and add an auxiliary label telling the patient to measure carefully
• d.Stop the fill and alert the pharmacist, because the unit of measure was changed from units to mL and would produce a massive overdose✓

Insulin is dosed in units, and 14 mL of U-100 insulin would contain 1,400 units — roughly a hundred times the intended dose — so the fill must stop and the pharmacist must correct the entry. The claim that 14 mL works out to 14 units is false, keeping the mL wording on the label preserves the error, and no auxiliary label or syringe choice can make a wrong unit of measure safe.

One shelf label in a pharmacy reads "hydrOXYzine" and another, stored some distance away, reads "hydrALAZINE." What is the purpose of writing the names this way?

• a.It marks the product as a controlled substance that must be kept in the safe rather than on the open shelf
• b.It highlights the letters that differ between two similar names so the products are less likely to be confused✓
• c.It identifies the part of the drug name that must be typed in capital letters on the patient's label
• d.It shows that the brand-name product must be dispensed because no generic version has been approved

TALL man lettering capitalizes the dissimilar portion of two confusable names so the eye is pulled to the difference rather than to the shared beginning. Controlled substance status is shown by the schedule and the storage requirements that follow from it, not by capitalization, and TALL man lettering says nothing about brand versus generic. The patient label uses ordinary lettering; the capitalization is a shelf and screen aid for staff.

A pharmacy stocks both clonazePAM and cloNIDine. Which storage practice best reduces the risk of pulling the wrong product?

• a.Separate them physically on different shelves and place a shelf alert at each location✓
• b.Highlight the letters the two names have in common so staff notice the similarity
• c.Stock only one of the two and order the other in when a prescription arrives
• d.Shelve them side by side in alphabetical order so both labels can be seen at once

Physical separation plus a shelf alert breaks the automatic reach-and-grab that causes look-alike errors, because the technician must move to a different location and read a warning before selecting. Strict alphabetical shelving is what places these two names next to each other in the first place; marking the letters the names share pulls the eye toward what they have in common, which is the opposite of what TALL man lettering does; and refusing to stock one of them would leave patients without a legitimately prescribed drug.

Which pair of medications is most likely to be involved in a look-alike/sound-alike selection error?

• a.lisinopril and warfarin
• b.predniSONE and predniSOLONE✓
• c.amoxicillin and metformin
• d.ibuprofen and cetirizine

predniSONE and predniSOLONE differ by only a few letters near the end of a long shared stem, sit next to each other alphabetically, and are stocked in similar strengths, which is the classic recipe for a wrong-drug selection. The other pairs share neither spelling, sound nor shelf position, so a technician reaching for one is unlikely to grab the other.

A patient's profile lists busPIRone 10 mg three times daily, but the bottle a technician pulled from the shelf is buPROPion 100 mg. Why was this error likely, and what would have prevented it?

• a.The two names look and sound alike; scanning the barcode and reading the full name with its TALL man lettering before counting would have prevented it✓
• b.The two drugs belong to the same therapeutic class, so checking the class printed on the shelf label would have prevented it
• c.The two drugs are supplied in identical tablet strengths, so comparing the strength on the bottle with the label would have prevented it
• d.The two drugs share the same labeler code in their NDC numbers, so comparing the manufacturers would have prevented it

busPIRone and buPROPion share their first three letters and a similar rhythm, which is why they appear on look-alike/sound-alike lists; a barcode scan plus a deliberate reading of the capitalized portion catches the substitution before any tablets are counted. They are not in the same therapeutic class, they do not necessarily come from the same labeler, and their strengths in this scenario are 10 mg and 100 mg rather than identical.

A stock bottle carries the NDC 00093-0058-01. In the 11-digit 5-4-2 format, what does the middle segment identify?

• a.The manufacturer or labeler that registered the product with the FDA
• b.The package size and the type of container the drug is supplied in
• c.The controlled substance schedule the DEA has assigned to the drug
• d.The specific drug product, meaning its active ingredient, strength and dosage form✓

The three segments run labeler, product and package: the first five digits identify the company, the middle four identify the drug together with its strength and dosage form, and the last two identify the package size. So a change in strength from 10 mg to 20 mg changes the middle segment. Controlled substance schedule is not encoded anywhere in the NDC.FDA

Two bottles from the same manufacturer carry NDC numbers that are identical except for the final two digits. What does this most likely mean?

• a.The two bottles contain different strengths of the same active ingredient
• b.The bottles hold the same drug, strength and dosage form but in different package sizes✓
• c.One bottle is the brand product and the other is its authorized generic
• d.One of the two bottles came from a lot that has passed its expiration date

Only the package segment differs, so the products are identical in ingredient, strength and dosage form and vary only in package size — for example a 100 count bottle versus a 500 count bottle. A brand-to-generic change would alter the labeler segment, a change in strength would alter the product segment, and expiration dating is printed separately and is never part of the NDC.

Which practice best confirms that the stock bottle in hand is the exact product called for by the prescription label?

• a.Compare the lot number on the bottle with the prescription number
• b.Compare the manufacturer's logo on the bottle with the image shown in the dispensing software
• c.Compare only the drug name printed on the label with the name on the bottle
• d.Compare the full 11-digit NDC on the stock bottle with the NDC on the prescription label, segment by segment✓

Matching all 11 digits verifies manufacturer, drug, strength, dosage form and package size in a single check, which is why the NDC is the anchor for both manual and barcode verification. Reading the name alone misses strength and dosage form errors, the lot number and prescription number are unrelated fields, and a logo confirms only the company.

At the pickup window a patient asks the technician whether her new antibiotic will interfere with her birth control pill. What should the technician do?

• a.Read the interaction section of the package insert aloud to the patient
• b.Refer the question to the pharmacist, who is responsible for patient counseling✓
• c.Suggest that the patient look it up on the manufacturer's website
• d.Answer using the interaction screen in the dispensing software

Interpreting a drug interaction for a specific patient is clinical judgment and counseling, which is the pharmacist's role; the technician's correct response is a prompt, courteous hand-off. Reading the insert aloud or repeating what the software screen says is still giving clinical advice, and sending the patient to a website leaves the question unanswered by the professional standing right there.

While entering a prescription for cephalexin, a technician sees a system alert that the patient has a documented penicillin allergy. What is the appropriate action?

• a.Remove the allergy from the profile if the patient says the reaction was mild
• b.Leave the alert unresolved and notify the pharmacist so it can be clinically evaluated✓
• c.Cancel the prescription and tell the patient to contact the prescriber
• d.Override the alert, since cephalexin is not a penicillin

Deciding whether a documented allergy contraindicates a related antibiotic is a clinical judgment reserved for the pharmacist, so the technician's job is to preserve the alert and escalate it. Overriding it, editing the allergy history based on a casual patient comment, or canceling the prescription outright all substitute the technician's judgment for the pharmacist's and can delay needed therapy.

Which step must be performed by the pharmacist before a completed prescription is released to the patient?

• a.Counting the tablets or measuring the liquid to be dispensed
• b.Applying the auxiliary warning labels to the finished container
• c.Scanning the barcode on the stock bottle before counting
• d.The final clinical and product verification of the finished prescription✓

Final verification is where a licensed pharmacist confirms that the right drug, strength, quantity and directions match the prescription and that the therapy is appropriate for that patient, and it cannot be delegated to a technician. Counting, labeling and barcode scanning are all technical tasks a technician performs, and none of them substitutes for the pharmacist's clinical review.

A prescriber's office telephones the pharmacy to give a new prescription. In most states, what should the technician do?

• a.Ask the caller to repeat the order twice, write it down, and file it as a written prescription
• b.Take the order as long as the drug is not a controlled substance and the caller is a licensed nurse
• c.Take the order, enter it into the computer, and have the pharmacist verify the entry afterward
• d.Transfer the call to the pharmacist, because accepting a new verbal prescription is outside the technician's scope in most states✓

Receiving a new oral prescription requires professional judgment about the drug, dose and directions as they are spoken, so most state boards restrict it to the pharmacist and the correct action is to hand off the call. Entering it first and verifying later means the error has already been recorded, a nurse relaying an order does not change the technician's scope, and repeating an order does not convert a verbal prescription into a written one.

In what sequence should personnel garb before entering the buffer area to prepare sterile compounded products?

• a.Mask, gown, shoe covers, hair cover, hand hygiene, sterile gloves
• b.Shoe covers, hair and beard cover, mask, hand hygiene, gown, sterile gloves✓
• c.Hand hygiene, sterile gloves, gown, mask, hair cover, shoe covers
• d.Gown, shoe covers, hair cover, mask, hand hygiene, sterile gloves

Garbing moves from the dirtiest items to the cleanest — feet, then head, then face — with hand hygiene performed after the head and face coverings are in place and immediately before the gown and sterile gloves. All jewelry, watches and artificial or extended nails must be removed before this sequence begins. The other sequences put gloves or gown on before hand hygiene or before the head coverings, which contaminates what has already been donned.USP <797>

While compounding in a horizontal laminar airflow workbench, a technician sets a stack of supplies between the HEPA filter and an open vial. Why is this unsafe?

• a.It blocks the technician's view of the syringe graduations, so the volume drawn up cannot be read accurately
• b.It raises the temperature inside the hood above the range the compounding area must be kept in
• c.It interrupts first air, so the critical site no longer receives unobstructed HEPA-filtered air and may become contaminated✓
• d.It sets off the pressure differential alarm that monitors airflow through the hood, forcing a restart

First air is the clean air leaving the HEPA filter before it touches anything, and any object placed upstream of a critical site creates turbulence and a shadow of unfiltered air over that site. Work should be performed at least 6 inches inside the hood with nothing between the filter and the vial or needle. Temperature limits, alarms and sightlines are not the reason the practice is prohibited.USP <797>

Immediately before puncturing a vial inside the hood, what should the technician do to the rubber septum?

• a.Wipe it with sterile 70% isopropyl alcohol and allow it to air-dry before puncturing✓
• b.Rinse it with sterile water for injection and then puncture it right away
• c.Hold it briefly over an open flame to sterilize the rubber surface
• d.Wipe it with a dry sterile gauze pad to remove any dust from the surface

Sterile 70% isopropyl alcohol needs contact time to kill surface organisms, so the septum must be wiped in one direction and then allowed to dry rather than being punctured while still wet. A dry gauze pad only moves contamination around, sterile water has no antimicrobial action, and open flame is never used in a laminar airflow hood.

A technician is assigned to prepare an intravenous dose of a hazardous antineoplastic drug. Which combination of personal protective equipment and engineering control is required?

• a.Two pairs of chemotherapy-rated gloves and a disposable low-permeability gown, working in a negative-pressure containment device✓
• b.Chemotherapy gloves with no gown, working in a positive-pressure clean bench
• c.One pair of examination gloves and a cloth lab coat, working in a horizontal laminar airflow bench
• d.Sterile gloves and a surgical mask only, working at an open bench with a portable fume extractor

Hazardous drug compounding requires double chemotherapy-rated gloves and a closed-front, low-permeability disposable gown inside a containment primary engineering control that keeps airflow moving inward and vents appropriately, protecting the preparer as well as the preparation. A horizontal or positive-pressure clean bench blows air outward toward the operator, and examination gloves, cloth coats or a mask alone provide no barrier against hazardous drug residue.USP <800>

A technician pulls the wrong strength of a medication but notices the mistake and corrects it before the pharmacist's final check, so the patient is never affected. Under a just-culture approach, what should happen next?

• a.The near miss should be documented and reported internally so the underlying system weakness can be analyzed and corrected✓
• b.It should be reported only if the same technician makes the same mistake a second time later on
• c.The technician should receive formal written discipline so that the mistake is not repeated
• d.Nothing needs to be recorded, because the error was caught in time and no patient was harmed

Near misses are free lessons: reporting one lets the pharmacy run a root cause analysis and fix the shelf layout, label design or workflow that made the error possible before a patient is harmed. A just culture separates honest system-driven error from reckless behavior, so punishing the report or waiting for a repeat simply teaches staff to stay silent and leaves the hazard in place.

A patient develops a severe rash days after starting a newly dispensed sulfonamide antibiotic, and the pharmacist decides to report it to the FDA. Which program should be used?

• a.The manufacturer's product recall notification system, which alerts pharmacies to defective lots
• b.VAERS, the federal system that collects reports of adverse events following vaccination
• c.A DEA Form 106, the federal form used to report the loss or theft of controlled substances
• d.MedWatch, the FDA program for adverse events and product quality problems involving drugs and other medical products✓

MedWatch is the FDA's voluntary reporting pathway for suspected adverse drug reactions, medication errors and product defects, and reports from pharmacies help detect safety signals that clinical trials missed. VAERS is reserved for events after vaccines, DEA Form 106 covers controlled substance loss or theft, and a recall notification moves product off the shelf but is not a way to report a patient reaction.FDA

While a technician is entering a new prescription, the system fires a drug-interaction alert that the technician's log-in cannot bypass. What does this hard stop mean?

• a.The technician may key in the pharmacist's override code kept at the workstation
• b.The technician should delete one of the interacting drugs from the profile so the alert clears
• c.Only the pharmacist may review the alert and clear it before the fill continues✓
• d.The alert is informational and may simply be documented

A hard stop is built so that the clinical judgement behind an override is made and documented by the pharmacist; the technician's role is to leave the order in the queue and hand it over. Keying in a borrowed override code is the closest wrong answer because it does move the queue along, but it puts the technician's hands on a clinical decision and falsifies who reviewed the interaction. Deleting a drug from the profile destroys the very data the interaction check runs on.

Two strengths of the same manufacturer's product arrive in cartons that are identical except for a small color band. Which practice best reduces wrong-carton selection?

• a.Store the two strengths in separate labelled bins with an auxiliary warning on each✓
• b.Cover the manufacturer's color band with the pharmacy's own strength label
• c.Apply tall man lettering to both shelf labels, since that is the standard fix for look-alike products
• d.Shelve them side by side in strength order so the difference is obvious

When the confusable feature is the packaging rather than the name, the control has to be physical: separate the strengths and add a warning that forces a second look. Tall man lettering is the tempting answer because it is the standard look-alike remedy, but it differentiates spelling, and here the two names are identical, so it changes nothing. Shelving them adjacently in strength order actually raises the risk, because the near-identical cartons then sit within one reach, and covering manufacturer labelling obscures information the pharmacist needs at verification.

A community pharmacy runs an automatic refill program for maintenance prescriptions. Which control matters most to the safety of that program?

• a.Enrolling every maintenance prescription automatically so that no chronic therapy ever lapses
• b.Adding Schedule II prescriptions to the program so that patients do not run out between visits
• c.Letting the pharmacist catch any discontinued drug at the final verification step
• d.Confirming with the patient each cycle that the drug is still being taken as prescribed✓

The characteristic auto-refill harm is a drug that the prescriber stopped or changed being filled, delivered and then taken again, so the program needs a live confirmation from the patient at each cycle. Waiting for the pharmacist's final verification is the closest wrong answer, because that check does happen, but it compares the label to the prescription on file and cannot see a change the pharmacy was never told about. Auto-enrolling everything removes the patient's consent, and Schedule II prescriptions cannot be refilled at all under federal law, so they can never be part of a refill program.

A recall notice arrives naming one specific lot number of a tablet the pharmacy stocks. What should the technician do with the pharmacy's stock of that drug?

• a.Pull the named lot, quarantine it away from active stock, and follow the notice✓
• b.Leave the lot on the shelf but flag the computer record so that it is never dispensed
• c.Pull every bottle of the drug regardless of lot and send all of it back
• d.Discard the affected bottles in the pharmaceutical waste bin

A lot-specific recall is handled by removing that lot from where anyone can reach it, holding it in a marked quarantine area separate from dispensable stock, and doing exactly what the notice instructs about return or destruction. Flagging the computer record is the closest wrong answer because it does block the sale, but the physical bottle stays within arm's reach of the fill station, and a computer flag cannot stop a hand. Pulling every lot destroys usable inventory the notice never covered, and discarding the bottles gives up the documented return the manufacturer needs.

A patient returns a sealed, unopened bottle of tablets the pharmacy dispensed last week and asks that it be restocked and credited. In most states, what should the pharmacy do?

• a.Decline to restock it; medication that has left the pharmacy cannot be verified✓
• b.Repackage the tablets into a new vial for the next patient on the same drug
• c.Restock it after the pharmacist inspects the tablets and matches the lot
• d.Restock it, because the manufacturer's seal is unbroken and the fill is under 30 days old

Once a dispensed medication leaves the pharmacy's control, nobody can confirm how it was stored or handled, so in most states it cannot go back into dispensable stock even if the seal looks untouched. Pharmacist inspection is the closest wrong answer, because inspection and lot matching are real controls, but neither reconstructs the temperature history of a bottle that spent a week in a car or a bathroom. Repackaging it for another patient carries the same unverifiable product forward under a new label.

A refrigerated biologic has to reach a patient's home by pharmacy courier. Which practice best protects the product in transit?

• a.Send it by ordinary courier and tell the patient to refrigerate it on arrival
• b.Pack it in an insulated bag with ice cubes and leave it at the door if nobody answers
• c.Freeze the product before it leaves so that it stays cold for the entire trip
• d.Pack it in a validated insulated shipper with a temperature indicator and obtain a signature on delivery✓

Cold-chain transport is only defensible when the container has been validated to hold the range for the expected trip time and the indicator lets someone read afterwards whether it actually did, with a signature proving the product was not left in the sun. Ice cubes plus a doorstep drop is the closest wrong answer because the insulation is at least present, but melting ice gives no record and an unattended package has no controlled temperature at all. Freezing is worse than doing nothing for most refrigerated biologics, which are damaged by it.

In a long-term-care pharmacy a technician fills unit-dose medication carts for the next 24 hours. Which check best keeps a cart-fill error from reaching a resident?

• a.Filling from the previous cycle's cart list, since residents' regimens rarely change much
• b.Filling from the current medication administration record and having the pharmacist verify the cart before it leaves✓
• c.Having a second technician confirm that the drawer count matches the resident census
• d.Relying on the nurse's check at the bedside as the last chance to catch the error

Cart fill is only as good as the document it is filled from, so the fill must start from the current medication administration record and end with a pharmacist verification while the cart is still in the pharmacy and errors are cheap to fix. The bedside nurse check is the closest wrong answer, because it is a genuine last line of defense, but it happens after the cart has travelled and it is the control the pharmacy cannot manage. Counting drawers against the census confirms quantity, not that the right drug reached the right resident.

A prescriber writes 'QD' on an order for a once-daily medication. Why does ISMP's list of error-prone abbreviations ask that this be written out as 'daily'?

• a.QD is easily misread as QID or QOD✓
• b.QD gives no route, so the order cannot be filled
• c.QD resembles OD, the abbreviation for the right eye
• d.QD is banned only in handwriting

The letters and the period in QD are readily read as QID or as QOD, so a once-daily drug can end up given four times a day or every other day. Confusion with OD, the abbreviation for the right eye, is a genuine hazard that ISMP also lists, but it is a route error rather than the frequency error that put QD on the list. A missing route is a separate defect, and the abbreviation is discouraged in typed orders as well as handwritten ones.

An order for an oral liquid is written as '.5 mg'. How should that dose have been expressed, and why?

• a.0.50 mg, because a second decimal place records that the dose was checked
• b.500 mcg, because ISMP bars stating a dose as a fraction of a milligram
• c.0.5 mg, because a bare decimal point can be missed and read as 5 mg✓
• d.1/2 mg, because a fraction cannot be read as a whole number

A decimal point with nothing in front of it disappears on a fax, a carbon copy or a smudged page, so .5 mg is read as 5 mg — a tenfold overdose. Rewriting the dose in micrograms is the tempting alternative and is a reasonable way to avoid decimals, but the reason given is false: ISMP does not forbid sub-milligram doses, it requires the leading zero. A trailing zero such as 0.50 mg is the opposite error and is also on the do-not-use list, because a lost decimal point makes it read as 50 mg.

A handwritten hospital order reads 'MS 4 mg IV q4h PRN pain.' Why is the order returned to the prescriber before it is processed?

• a.MS is a brand abbreviation, and brands are barred from inpatient orders
• b.MS orders must also carry a concentration expressed in mg per mL
• c.MS can mean morphine sulfate or magnesium sulfate✓
• d.MS is an oral-only abbreviation

MS and MSO4 have been read as magnesium sulfate when morphine sulfate was meant, and the reverse, which is why ISMP requires the drug name to be spelled out in full. The missing concentration is a real labeling concern and is the closest call here, but a concentration would not resolve which of the two drugs was ordered — the ambiguity is in the name itself. MS is not a brand name, and it is not limited to the oral route.

A pharmacy requires an independent double check on every insulin infusion prepared in the IV room. What makes the second check 'independent'?

• a.The second person repeats the calculation aloud while the first person confirms it
• b.The second check is recorded on a separate log sheet
• c.The second check is done by staff from a different department
• d.The second person checks the work alone, without seeing the first result✓

Independence means the second person works from the original order and reaches a conclusion without being told what the first person concluded; only then can the check catch the first person's error. Reading the calculation aloud together is the tempting choice because it feels like verification, but the second person is anchored to a result already spoken and tends to confirm it. Neither the checker's department nor where the record is filed has any bearing on independence.

Concentrated potassium chloride injection has killed patients who received it undiluted. Which system change did hospitals widely adopt in response?

• a.Concentrated vials stayed in floor stock but were sealed in a red high-alert overwrap
• b.Concentrated vials were removed from floor stock in favor of premixed bags✓
• c.Nurses were required to dilute the concentrate at the bedside before every dose
• d.Only pharmacists were allowed to sign the vials out

The concentrated vials were taken off nursing units altogether and commercially premixed, ready-to-hang bags were supplied instead, because undiluted potassium chloride given by IV push causes cardiac arrest within seconds. Adding warning stickers while leaving the vials on the unit is the plausible-sounding option, and it was tried — it did not stop the deaths, because a hurried nurse still had a lethal vial within reach. Bedside dilution is exactly the step this change was designed to eliminate.

On a hospital unit a nurse asks whether an insulin pen already used for one patient may be used for a second patient if a fresh needle is attached and the pen barrel is wiped with alcohol. What is correct?

• a.Yes, provided a new needle is attached at the bedside and the pen is relabeled
• b.Yes, because the cartridge is a closed system the needle never touches
• c.No, an insulin pen is dedicated to a single patient✓
• d.Only if the pen holds a long-acting insulin rather than a rapid-acting one

Insulin pens are single-patient devices: blood and tissue can be drawn back into the cartridge during an injection, so changing the needle does not make the pen safe for anyone else. The closed-system argument is the tempting one, but backflow into the cartridge has been demonstrated, which is why the FDA and CDC warned against sharing pens even with a new needle each time. The insulin inside the pen has no bearing on the rule.

A hospital expands the traditional five rights to eight by adding right documentation, right reason and right response. What does 'right response' require?

• a.Checking whether the drug produced the effect it was given for✓
• b.Checking that the order matches the diagnosis recorded in the chart
• c.Checking that the dose was charted within the required time
• d.Checking that the patient consented before the dose

Right response closes the loop: after the dose, someone confirms that the pain score fell, the blood pressure came down or the fever broke, and that no adverse effect appeared. Matching the order to the recorded diagnosis is the close call, but that is right reason — it asks why the drug was ordered, not what it did. Charting the dose on time is right documentation, and consent is not one of the eight rights.

Two finished prescriptions sit in the will-call bin for a father and a son who share the same first and last name. Which practice best prevents handing over the wrong bag?

• a.Ask which drug the patient expects and match it to the label
• b.Sort the two bags into separate bins by middle initial
• c.Staple the two bags together and hand over both
• d.Confirm the date of birth as well as the name✓

Two identifiers are the standard: the name plus a second item such as date of birth or street address, which is what separates a father from a son with the same name. Asking which drug the patient expects sounds practical and is the closest alternative, but a family member frequently collects for both and can name either drug, so it confirms nothing about identity. Bin sorting only helps the staff find the bag, and releasing both bags at once is the wrong-patient handoff the check exists to stop.

A technician scans the barcode on the stock bottle and the dispensing system accepts it as a match for the label. Which error does that scan still leave undetected?

• a.That the bottle holds a strength other than the one the label calls for
• b.That the package size differs from the quantity dispensed
• c.That the prescription was entered under the wrong patient's name✓
• d.That the manufacturer differs from the previous fill

The barcode carries the NDC, and the NDC identifies the labeler, the product — drug, strength and dosage form — and the package size, so all of those are compared against what was entered. The NDC says nothing about who the prescription is for, so a wrong-patient data-entry error passes the scan cleanly and has to be caught by verifying identity at entry and again at the point of sale.

A wholesaler's invoice lists the NDC 0093-0058-01 in the 10-digit 4-4-2 format. To convert it to the 11-digit 5-4-2 format used on claims, where is the leading zero inserted?

• a.At the end of the package code
• b.In front of the product code, making it a five-digit segment
• c.In front of the package code, making a three-digit segment
• d.In front of the labeler code✓

A 4-4-2 number is short one digit in the labeler segment, so the zero is placed at the front of that segment and 0093-0058-01 becomes 00093-0058-01. Padding the product or package segment instead produces a number in 4-5-2 or 4-4-3 shape, which is not a valid NDC configuration and will either reject at the processor or, worse, match a different product than the one dispensed.

Which published resource names the specific drug pairs a pharmacy should display using tall man lettering?

• a.The manufacturer's package insert for each affected product
• b.The FDA Orange Book therapeutic equivalence codes
• c.The FDA Purple Book
• d.The ISMP List of Confused Drug Names✓

ISMP maintains the List of Confused Drug Names, which pairs look-alike and sound-alike products and marks the pairs for which tall man lettering such as buPROPion and busPIRone is recommended. The Orange Book rates therapeutic equivalence between generics and their reference products, and the Purple Book lists licensed biologics; neither addresses name confusion. A package insert describes one product and cannot tell you which other product it is mistaken for.

In most states a pharmacist must counsel, or offer to counsel, at the point of sale. For which of these four patients is counseling most clearly indicated?

• a.A patient refilling the same lisinopril strength he has taken for two years
• b.A neighbor collecting a housebound patient's refill
• c.A patient buying an OTC pain reliever at the register
• d.A patient starting weekly oral methotrexate for the first time✓

A first fill of weekly oral methotrexate is the clearest trigger: it is a new prescription, and taking the tablets daily instead of once a week has killed patients, so the directions themselves are the hazard being counseled on. An unchanged refill of a long-standing drug is the close call, since an offer is usually still made, but nothing about the therapy has changed. Counseling can be left for the patient when an agent collects a routine refill, and a plain over-the-counter purchase carries no counseling duty.

A manufacturer recalls a lot of tablets that assayed subpotent, and the FDA classifies it as a Class II recall. What does that classification say about the health risk?

• a.Use carries a reasonable probability of serious harm or death
• b.Use is unlikely to cause any adverse effect
• c.Use may cause temporary or medically reversible harm✓
• d.The firm removes the product voluntarily

Class II covers products whose use may cause temporary or medically reversible adverse health consequences, with only a remote probability of serious harm — a subpotent lot fits, because the patient is underdosed for a period but the consequence is generally reversible. Class III, reserved for products unlikely to cause any adverse effect such as a lot with a label typo, is the tempting near miss. Class I requires a reasonable probability of serious injury or death, and a market withdrawal is not an FDA recall class at all.

A patient who received an influenza vaccine at the pharmacy calls two days later with a large, swollen, painful arm and a fever. To which federal system should this reaction be reported?

• a.MedWatch, the FDA program for drug and device problems
• b.The Vaccine Adverse Event Reporting System✓
• c.The ISMP national medication error reporting program
• d.The CDC's National Healthcare Safety Network

Adverse events following immunization go to VAERS, the reporting system co-managed by the FDA and CDC specifically for vaccines, and reports are accepted from pharmacists, other clinicians and patients alike. MedWatch is the close call because it is the FDA's general safety-reporting program, but vaccine reactions are routed to VAERS instead. ISMP's program collects medication errors rather than reactions, and NHSN collects healthcare-associated infection data from facilities.

After correcting a dispensing error internally, a pharmacy also submits a de-identified account of it to ISMP's national medication errors reporting program. What is the purpose of that external report?

• a.To share the hazard nationally so other pharmacies can avoid it✓
• b.To satisfy a federal requirement that every dispensing error be reported
• c.To create a record the pharmacy can use if the patient later sues
• d.To shift responsibility for the error onto the manufacturer

The ISMP program is voluntary and confidential, and its value is that a hazard discovered in one pharmacy is analyzed and published so that pharmacies everywhere can change a label, a shelf or a workflow before the same error reaches their patients. The federal-requirement option is the tempting one, but no federal rule compels reporting of every dispensing error; state boards set their own, much narrower duties. The report is not built as a legal defense and does not transfer responsibility to anyone.

A hospital convenes a root cause analysis after a patient receives a tenfold insulin overdose. What distinguishes a root cause analysis from a failure mode and effects analysis?

• a.It scores each step of a process for how likely it is to fail
• b.It identifies the individual whose action caused the event
• c.It looks back at an event that already happened to find the system failures behind it✓
• d.It is conducted before a new process is put into use

A root cause analysis is retrospective: it starts from an event that already harmed someone and works backward through the process to the system weaknesses that allowed it. A failure mode and effects analysis is the mirror image in time — it is done prospectively, before or during a process change, and scores each step for how it could fail and how badly. Stopping at the individual whose hand was on the syringe is exactly what a root cause analysis is designed not to do.

During a long queue a technician knowingly skips the required barcode scan because the scanner is slow and the product looks obviously right. Under a just-culture model, how is that behavior classified and answered?

• a.Human error, met with consoling and a redesign of the scanning step
• b.Reckless behavior, met with disciplinary action up to termination
• c.A knowledge gap, met with mandatory retraining
• d.At-risk behavior, met with coaching and a fix to the workflow✓

Skipping a required step because it feels slow and the risk feels small is at-risk behavior: the technician drifted from the rule without seeing the danger, so the response is coaching plus removing what makes the shortcut attractive, such as fixing the slow scanner. Reckless behavior is the close call and is the label many people reach for, but it means consciously disregarding a substantial and unjustifiable risk — here the technician believed the risk was negligible. Human error is an unintended slip, which a deliberate choice is not, and the technician already knew the rule.